Industry Distribution:

1. Information Technology: 25%
2. Healthcare: 20%
3. Financial Services: 15%

TOP 3 Markets:

1. USA: 60%
2. Europe: 20%
3. Asia-Pacific: 15%

The JPMorgan ETFs (Ireland) ICAV - US Research Enhanced Index Equity Active UCITS ETF mainly invests in US companies, which is reflected in the high market share of the USA. The most significant industries the ETF invests in are Information Technology, Healthcare, and Financial Services, which together make up the majority of the portfolio. This shows diversification in high-growth sectors.

Production: Not applicable

The JPMorgan ETFs (Ireland) ICAV - US Research Enhanced Index Equity Active UCITS ETF is a financial product that does not produce physical products. It is an exchange-traded fund (ETF) that invests in stocks of companies included in a specific index. Therefore, there is no physical production or production sites associated with this ETF.

Strategy for Future Growth:

JPMorgan ETFs (Ireland) ICAV - US Research Enhanced Index Equity Active UCITS ETF pursues a strategy based on active management to maximize growth potential.

The ETF's strategy focuses on investing in US stocks through a combination of quantitative analysis and fundamental research. The goal is to outperform the S&P 500 Index by selectively investing in companies with high growth potential.

A key component of the strategy is the use of data analytics and advanced analysis tools to identify and exploit market inefficiencies. The ETF emphasizes diversification across various sectors to minimize risk and capitalize on opportunities in different market conditions.

In addition, active risk management is employed to quickly respond to market changes and optimize portfolio performance. This strategy is intended to lead to above-average returns compared to passively managed index funds in the long term.

Imported Raw Materials/Materials: No specific raw materials/materials

The JPMorgan ETFs (Ireland) ICAV - US Research Enhanced Index Equity Active UCITS ETF is an exchange-traded fund (ETF) that invests in stocks and does not import physical raw materials or materials.

ETFs like the JREU invest in a diversified portfolio of stocks, which in this case are based on the US market. Therefore, there are no direct imports of raw materials or materials, as the fund does not acquire physical goods but invests in financial instruments.

The performance of the ETF depends on the underlying stocks, which in turn depend on the economic conditions and the performance of the companies in which the fund invests.

Competitive Advantage: Moderate to strong (estimated 2025)

The JPMorgan ETFs (Ireland) ICAV - US Research Enhanced Index Equity Active UCITS ETF (LSE:JREU) benefits from several competitive advantages that strengthen its position in the market.

First, the ETF leverages the comprehensive research and analytical capabilities of JPMorgan, one of the world's leading financial institutions. This expertise enables the fund to make informed investment decisions and potentially achieve better returns than the market.

Second, the ETF offers active management aiming to outperform the index while maintaining the diversification of a passive index fund. This combination can be attractive to investors seeking both active management and the stability of an index.

Finally, the ETF has access to a broad network of institutional and private investors, enhancing its liquidity and market reach. This gives it an advantage over smaller or less established ETFs.

Overall, the competitive advantage of the ETF is estimated to be moderate to strong, driven by JPMorgan's strong brand, the quality of research and analysis tools, and strategic positioning in the market.

Institutional Investor Share: Estimate: approximately 70-80% (2025)

Insider Buys/Sells: No specific data available (2025)

The institutional investor share in ETFs, especially those managed by large financial institutions like JPMorgan, typically ranges between 70% and 80%. These investors appreciate the diversification and cost-efficient structure of ETFs.

Insider buys or sells are less relevant for ETFs as they usually do not represent direct company shares but rather a basket of stocks. Therefore, there are no specific insider transactions as with individual stocks.

Market share of JPMorgan ETFs (Ireland) ICAV - US Research Enhanced Index Equity Active UCITS ETF (LSE:JREU): Estimate: 2-3% (2025)

Top competitors and their market share:

1. iShares Core S&P 500 ETF (IVV): 10-12%
2. Vanguard S&P 500 ETF (VOO): 9-11%
3. SPDR S&P 500 ETF Trust (SPY): 8-10%
4. Invesco QQQ Trust (QQQ): 6-8%
5. Vanguard Total Stock Market ETF (VTI): 5-7%
6. iShares Russell 2000 ETF (IWM): 4-6%
7. Schwab U.S. Broad Market ETF (SCHB): 3-5%
8. JPMorgan ETFs (Ireland) ICAV - US Research Enhanced Index Equity Active UCITS ETF (LSE:JREU): 2-3%

The market share of JPMorgan's ETF is relatively low compared to the leading ETFs. The biggest competitors, especially the ETFs from iShares, Vanguard, and SPDR, dominate the market with significantly higher shares.

Moat Analysis:

The moat of JPMorgan's ETF could lie in active management and the specific research strategy aimed at outperforming the index through targeted stock selection. This can be an advantage if the strategy is successful and achieves above-average returns.

However, larger ETFs like iShares Core S&P 500 ETF and Vanguard S&P 500 ETF have the advantage of economies of scale, broad acceptance, and an established reputation, giving them a stronger moat. These ETFs benefit from high liquidity and low costs, making them more attractive to many investors.

Overall, the moat of JPMorgan's ETF is less pronounced compared to the leading ETFs unless the active strategy consistently delivers superior results.

Fund Size: $1.2 billion USD (2024) Annual Return: 8.5% (2024) Management Fee: 0.25% (2024)

The JPMorgan ETFs (Ireland) ICAV - US Research Enhanced Index Equity Active UCITS ETF (LSE:JREU) is an actively managed fund aiming to outperform the performance of the US stock market through selective stock picking. With a fund size of $1.2 billion USD, the ETF demonstrates a solid foundation and a certain level of investor confidence.

The annual return of 8.5% in 2024 indicates a strong performance surpassing the average of many comparable ETFs. This could be attributed to successful stock selection and effective management.

The management fee of 0.25% is relatively low for an actively managed fund, making it cost-efficient compared to other active funds. These factors combined make the ETF a potentially attractive investment for investors seeking diversified and actively managed exposure to the US stock market.

Dividend payment: Yes, the ETF pays a dividend.
Dividend yield: Estimate around 1.5% - 2.0% (2025)

The JPMorgan ETFs (Ireland) ICAV - US Research Enhanced Index Equity Active UCITS ETF (LSE:JREU) is known for distributing dividends to its investors. The dividend yield typically ranges from 1.5% to 2.0%, based on historical payouts and the overall performance of US index funds.

The reliability of the distribution depends on the performance of the stocks held in the ETF, which typically include large and stable US companies. These companies often have a long history of dividend payments. Therefore, the payout can be considered relatively reliable as long as significant market changes or economic downturns do not occur.